EUVIMEDEUVIMED entdecken
Crossref

Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews

Emilia M Swietlik, Michaela Fay, Nicholas W Morrell

Respiration · 09.09.2024 · 1-14

DOI: 10.1159/000540556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiration, online erschienen am 09.09.2024. Verfasst von Emilia M Swietlik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Establishing a diagnosis is paramount in medical practice as it shapes patients’ experiences and guides treatment. Patients grappling with rare diseases face a triple challenge: prolonged diagnostic journeys, limited responses to existing therapies, and the absence of effective monitoring tools. Genetic diagnosis often provides crucial diagnostic and prognostic information, opening up possibilities for genotype-targeted treatments and facilitating counselling and relative testing. The NIHR BioResource – Rare Diseases (NBR) Study and the Cohort Study in Idiopathic and Hereditary Pulmonary Arterial Hypertension (PAH Cohort study) aimed to enhance diagnosis and treatment for PAH, successfully identifying the genetic cause in 25% of idiopathic cases. However, the diagnostic and therapeutic odyssey in patients with PAH remains largely unexplored.

Methods

Stakeholders from the NBR and PAH Cohort studies were recruited using purposive sampling. In-depth interviews and focus groups were recorded, transcribed, anonymised, and analysed thematically using MAXQDA software.

Results

The study involved 53 interviews and focus groups with 63 participants, revealing key themes across five stages of the diagnostic odyssey: initial health concerns and interactions with general practitioners, experiences of misdiagnosis, relief upon receiving the correct diagnosis, and mixed emotions regarding genetic results and the challenges of living with the disease. Following the diagnosis, participants embarked on a therapeutic journey, facing various challenges, including the disease’s impact on professional and social lives, the learning curve associated with understanding the disease, shifts in communication dynamics with healthcare providers, therapeutic hurdles, and insurance-related issues. Building on these insights, we identified areas of unmet needs, such as improved collaboration with primary care providers and local hospitals, the provision of psychological support and counselling, and the necessity for ongoing patient education in the ever-evolving realms of research and therapy.

Conclusions

The study highlights the significant challenges encountered throughout the diagnostic and therapeutic journey in PAH. To enhance patient outcomes, it is crucial to raise awareness of the disease, establish clear diagnostic pathways, and seamlessly integrate genetic diagnostics into clinical practice. Streamlining the diagnostic process can be achieved by utilising existing clinical infrastructure to support research and fostering better communication within the NHS. Moreover, there is an urgent need for more effective therapies alongside less burdensome drug delivery methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionHypertension, PulmonaryHumansMaleFemaleMiddle AgedAdultInterviews as TopicFocus GroupsQualitative ResearchDiagnostic ErrorsGenetic Testing

Stichwörter der Autor:innen

Diagnostic odysseyGenetic counsellingGenetic testingIdiopathic/hereditary pulmonary arterial hypertensionTherapeutic odyssey

Autor:innen und Institutionen

  • Department of Medicine, The Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Department of Pulmonology, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
  • Respiratory Medicine Department, Addenbrooke's Hospital, Cambridge, UK.
  • MF Research Consultancy, Newcastle, UK.

Zitieren

APA

Swietlik, E. M., Fay, M., & Morrell, N. W. (2024). Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews. Respiration, 1-14. https://doi.org/10.1159/000540556

Vancouver

Swietlik EM, Fay M, Morrell NW. Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews. Respiration. 2024:1-14. doi:10.1159/000540556

BibTeX
@article{Swietlik2024,
  author = {Swietlik, Emilia M and Fay, Michaela and Morrell, Nicholas W},
  title = {Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews},
  journal = {Respiration},
  year = {2024},
  pages = {1--14},
  doi = {10.1159/000540556}
}
Kostenlos starten →